Is patient exposure preapproval and postapproval a determinant of the timing and frequency of occurrence of safety issues?
Alexandra C. Pacurariu; Christina E. Hoeve; Peter Arlett; Georgy Genov; Jim Slattery; Miriam C.J.M. Sturkenboom; Sabine M.J.M. Straus
Author Information: Medicines Evaluation Board
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.